(Q36932728)

English

Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial

scientific article published on May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial (English)

1 reference

Europe PubMed Central

17 August 2017

phase II clinical trial

0 references

multicenter clinical trial

0 references

5

object named as

Laura J Esserman

1 reference

Europe PubMed Central

17 August 2017

author name string

John A Olson

1

1 reference

Europe PubMed Central

17 August 2017

G Thomas Budd

2

1 reference

Europe PubMed Central

17 August 2017

Lisa A Carey

3

1 reference

Europe PubMed Central

17 August 2017

Lyndsay A Harris

4

1 reference

Europe PubMed Central

17 August 2017

Gini F Fleming

6

1 reference

Europe PubMed Central

17 August 2017

Paul K Marcom

7

1 reference

Europe PubMed Central

17 August 2017

George S Leight

8

1 reference

Europe PubMed Central

17 August 2017

Therese Giuntoli

9

1 reference

Europe PubMed Central

17 August 2017

Paul Commean

10

1 reference

Europe PubMed Central

17 August 2017

Kyongtae Bae

11

1 reference

Europe PubMed Central

17 August 2017

Jingqin Luo

12

1 reference

Europe PubMed Central

17 August 2017

Matthew J Ellis

13

1 reference

Europe PubMed Central

17 August 2017

publication date

1 May 2009

1 reference

Europe PubMed Central

17 August 2017

Journal of the American College of Surgeons

1 reference

Europe PubMed Central

17 August 2017

208

1 reference

Europe PubMed Central

17 August 2017

906-14; discussion 915-6

1 reference

Europe PubMed Central

17 August 2017

5

1 reference

Europe PubMed Central

17 August 2017

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

29 September 2017

Neoadjuvant endocrine therapy for locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

29 September 2017

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

29 September 2017

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

29 September 2017

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

29 September 2017

The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

29 September 2017

Preoperative endocrine therapy for older women with breast cancer: renewed interest in an old idea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

29 September 2017

The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

29 September 2017

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

4 September 2018

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

4 September 2018

Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

4 September 2018

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

4 September 2018

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

4 September 2018

The biomedical imaging resource at Mayo Clinic.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3683862

4 September 2018

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476859

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476859

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476859

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of Synthetic Oestrogens on Advanced Malignant Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476859

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgery as an adjunct to hormone therapy of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476859

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19476859

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.JAMCOLLSURG.2009.01.035

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36932728&oldid=1514880162"